Yip J, Facchini F S, Reaven G M
Department of Medicine, Stanford University School of Medicine, California, USA.
J Clin Endocrinol Metab. 1998 Aug;83(8):2773-6. doi: 10.1210/jcem.83.8.5005.
Resistance to insulin-mediated glucose disposal has been postulated to predispose individuals to a cluster of associated abnormalities (Syndrome X) known to increase risk of cardiovascular disease (CVD). Although several abnormalities subsumed under the rubric of Syndrome X have been shown to predict CVD, there has been no prospective study evaluating the power of insulin resistance, the putative fundamental defect in the syndrome, in this context. Therefore, this study was initiated to evaluate the hypothesis that resistance to insulin-mediated glucose disposal would predict the development of CVD in healthy volunteers. To accomplish this goal, 147 normal, healthy, nonobese, volunteers were evaluated [4.7 +/- 0.1 yr (mean +/- SEM)] after baseline measurements of steady state plasma glucose concentration (an estimate of insulin-mediated glucose disposal), as well as other CVD risk factors. Clinical end points developed in 13 subjects during the follow-up period; hypertension in 5, coronary artery disease in 4, cerebrovascular accident in 3, and peripheral vascular disease in 1. There was a significant univariate relationship between SSPG and CVD (P < 0.002), with the majority of the events taking place in the tertile of subjects with the highest SSPG concentration, i.e. the greatest degree of insulin resistance. In contrast, no CVD events were observed in the tertile with the lowest SSPG concentrations; the most insulin sensitive. SSPG was also related significantly to diastolic blood pressure, triglyceride, and low-density lipoprotein and high-density lipoprotein cholesterol concentrations, and the glucose and insulin responses to oral glucose. All of these relationships were independent of age, gender, body mass index, estimates of physical activity, and smoking history. When SSPG was paired with each of the other variables in a series of multiple regression models, only SSPG, or insulin response, were independent predictors of CVD events. In conclusion, approximately one of every five healthy, nonobese subjects in the most insulin-resistant tertile, followed for approximately 5 yr, had a serious clinical event. These data highlight the importance of insulin resistance as a predictor of CVD.
胰岛素介导的葡萄糖代谢抵抗被认为会使个体易患一系列相关异常情况(X综合征),已知这些异常会增加心血管疾病(CVD)的风险。尽管X综合征所包含的几种异常情况已被证明可预测CVD,但在此背景下,尚无前瞻性研究评估胰岛素抵抗(该综合征假定的根本缺陷)的预测能力。因此,开展本研究以评估胰岛素介导的葡萄糖代谢抵抗会预测健康志愿者发生CVD这一假设。为实现这一目标,在对稳态血浆葡萄糖浓度(胰岛素介导的葡萄糖代谢的一种估计)以及其他CVD危险因素进行基线测量后,对147名正常、健康、非肥胖志愿者[4.7±0.1岁(均值±标准误)]进行了评估。在随访期间,13名受试者出现了临床终点事件;5人患高血压,4人患冠状动脉疾病,3人发生脑血管意外,1人患外周血管疾病。稳态血浆葡萄糖(SSPG)与CVD之间存在显著的单变量关系(P<0.002),大多数事件发生在SSPG浓度最高的三分位数受试者中,即胰岛素抵抗程度最高者。相比之下,在SSPG浓度最低的三分位数受试者中未观察到CVD事件;这些受试者胰岛素敏感性最高。SSPG还与舒张压、甘油三酯、低密度脂蛋白和高密度脂蛋白胆固醇浓度以及口服葡萄糖后的葡萄糖和胰岛素反应显著相关。所有这些关系均独立于年龄、性别、体重指数、身体活动估计值和吸烟史。当在一系列多元回归模型中将SSPG与其他每个变量配对时,只有SSPG或胰岛素反应是CVD事件的独立预测因素。总之,在胰岛素抵抗程度最高的三分位数中,约每五名健康、非肥胖受试者中就有一人在随访约5年后发生了严重临床事件。这些数据突出了胰岛素抵抗作为CVD预测因素的重要性。